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Summary
The CE-MARC study is the largest, prospective evalua-
tion of cardiovascular magnetic resonance (CMR) in
patients with suspected coronary artery disease (CAD).
This predefined CE-MARC substudy compared the diag-
nostic performance of CMR and single-photon emission
computed tomography (SPECT) in the female cohort.
Background
Coronary artery disease (CAD) is the leading cause of
death in women but despite this they are often underre-
presented in non-invasive imaging studies. Furthermore,
the use of myocardial perfusion imaging in women pre-
sents challenges not encountered in men including a
low premenopausal prevalence of CAD, more atypical
symptoms, a different pattern of disease (more frequent
single-vessel disease and intermediate grade stenosis),
breast attenuation artefacts and smaller heart size. This
substudy aimed to compare the diagnostic performance
of CMR and single-photon emission computed tomogra-
p h y( S P E C T )i nt h ef e m a l ec o h o r to ft h eC E - M A R C
study [1].
Methods
CE-MARC was a prospective study of 752 patients with
suspected CAD. All patients were scheduled to undergo
CMR and SPECT followed by invasive coronary angio-
graphy (the reference standard). CMR comprised adeno-
sine stress/rest perfusion, cine imaging, late gadolinium
enhancement and MR coronary angiography. Gated ade-
nosine stress/rest SPECT was performed using 99mTc
tetrofosmin. Visual analysis was performed on a per
patient basis. For this pre-defined substudy, the diagnos-
tic accuracy of CMR and SPECT to detect significant
CAD in the female cohort (n = 281) was compared
using McNemar’s Chi-Squared Test and Leisenring’s
Generalised Score Statistic. In a secondary analysis,
receiver operating characteristic curves were generated
for the stress perfusion CMR component and SPECT
(using a summed stress scores for both).
Results
235 female patients had interpretable CMR, SPECT and
angiography. The prevalence of significant CAD was
22.6% (1VD 14.9%; 2VD 6.0%; 3VD 1.7%). The sensitiv-
ity of a multi-parametric CMR study was 88.7% (95%CI:
77.4-94.7), specificity 83.5% (95%CI: 77.4-88.2), positive
predictive value (PPV) 61.0% (95%CI: 49.9-71.2) and
negative predictive value (NPV) 96.2% (95%CI: 92.0-
98.2). For SPECT the sensitivity was 50.9% (95%CI:
37.9-63.9), specificity 84.1% (95%CI: 78.1-88.7), PPV
48.2% (95%CI: 35.7-61.0) and NPV 85.5% (95%CI: 79.6-
89.9). The differences between the sensitivity and NPV
of CMR and SPECT were highly significant (c2=18.18,
1df. P<0.001 and c2=19.63, 1df. P<0.001 respectively);
the difference between the PPVs was also significant
(c2=3.95, 1df. P=0.0468) but the specificities were not
significantly different (c2=0.02, 1df. P=1.000). In the sec-
ondary analysis, stress perfusion CMR (AUC: 0.90, 95%
CI 0.84-0.95) significantly out-performed SPECT (AUC:
0.67, 95%CI 0.59-0.75) (P<0.001; Fig 1).
Conclusions
CMR has significantly greater sensitivity, NPV and PPV
compared to SPECT for the detection of CAD in
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nation with an absence of ionising radiation exposure
mean that CMR should be considered the preferred
non-invasive imaging test for females with suspected
CAD.<p>
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Figure 1 The AUC was significantly higher for stress perfusion CMR
than for SPECT (AUC: 0.90 vs. 0.67; p<0.001)
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